TRANSTHYRETIN AMYLOID CARDIOPATHY
Clinical trials for TRANSTHYRETIN AMYLOID CARDIOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOID CARDIOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOID CARDIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to halt debilitating heart damage
Disease control TerminatedThis study aimed to see if a new drug called ION-682884 could slow or stop the progression of a serious heart condition called TTR amyloid cardiomyopathy. It was designed for a small group of older patients (65-85 years old) who had already completed a 24-month study with a simil…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOPATHY
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Pfizer launches major registry to map rare heart disease journey
Knowledge-focused OngoingThis study aims to learn more about a rare heart condition called ATTR-CM by observing 350 patients in Asia. It will not test any new treatments. Instead, it will collect information on how the disease progresses and what treatments patients receive in real-world medical care to …
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOPATHY
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC